Patents by Inventor Tobias Leander Lenz

Tobias Leander Lenz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY
    Publication number: 20220389102
    Abstract: Molecular determinants of cancer response to immunotherapy are described.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 8, 2022
    Inventors: Timothy A. Chan, Diego Chowell Puente, Chirag Krishna, Tobias Leander Lenz, Federica Pierini